Preliminary Program
September 22, 2021
Session 1: Advances in Glycobiotechnology
Application of Biocatalysis in Glycobiotechnology
Sabine Flitsch, University of Manchester, UK
Warren Wakarchuk, University of Alberta, Canada
C-type lectin receptor targeting to modulate immune responses during infections
Bernd Lepenies, University of Veterinary Medicine Hannover, Foundation (TiHo), Research Center for Emerging Infections and Zoonoses (RIZ), Germany
Véronique Blanchard, Charité Universitätsmedizin Berlin, Germany
Erdmann Rapp, glyXera GmbH, Germany
Glycouniverse GmbH, Germany
Session 2: Potentials and Challenges of Digitalization in R&D and in Healthcare
Critically ill COVID-19 associated trait genetics reveals CDK6 inhibitors as potential treatment
Marco Schmidt, Biotx.ai GmbH, Germany
Katja Uhlig, Fraunhofer Institute for Cell Therapy and immunology, Branch Bioanalytics and Bioprocesse (IZI-BB), Germany
Srujan Dondapathi, Fraunhofer Institute for Cell Therapy and immunology, Branch Bioanalytics and Bioprocesse (IZI-BB), Germany
September 23, 2021
Session 3: Trends in Antibody Technologies
Genetic Glycoengineering in Mammalian cells
Zhang Yang, University of Copenhagen and GlyoDisplay Aps, Denmark
Glycotope GmbH, Germany
Peter Sondermann, Tacalyx GmbH, Germany
Michael Hust, TU Braunschweig, Germany
Session 4: Emerging Concepts and Technologies in Vaccine Development
Targeted Delivery Systems for Antigen-Specific Immunotherapies
Robert Wawrzinek, Cutanos GmbH, Austria
RNA-based vaccines, technological challenge and opportunity for new therapies
Tilmann Roos, CureVac AG, Germany
Session 5: Innovations and Potentials through High-throughput Screenings
Jens Peter von Kries, FMP, Berlin, Germany
Niels Fertig, Nanion GmbH, Munich, Germany
September 24, 2021
Session 6: Translational Immunology in early life disease
in cooperation with the Monash University, Australia
Clinical proteomics: improving the outcomes for children
Vera Ignjatovic, University of Melbourne, Australia
New and emerging approaches to tackle the early life origins of disease
Dr Siroon Bekkering, Radboud Universitair Medisch Centrum, The Netherlands
David Burgner, Murdoch Childrens Research Institute, Australia
Samuel Forster
Hudson Institute of Medical Research, Australia (Research Group Head, Microbiota and Systems Biology)
Philip DeKoninck
Monash University, Australia
Jose Polo
Monash University, Australia
Andrew Currie
Murdoch University, Australia
Session 7: Medicine and Health of Aging – Research, Therapy and Health Care
in cooperation with the Faculty of Health Sciences Brandenburg, Germany
Medicine and Health of Ageing – Current Research at the Faculty of Health Sciences Brandenburg
René Mantke, Faculty of Health Sciences Brandenburg, Brandenburg Medical School, Brandenburg an der Havel
Prevention and Therapy
„Lauflabor“ and „Antepulse“ – Innovative Approaches for Improving Vascular Health of Risk Patients
Ivo Buschmann, Brandenburg Medical School, Brandenburg an der Havel“
Healthcare Research and Digital Health
Mobile molecular diagnostics of viral diseases in human and veterinary medicine
Frank Hufert, Brandenburg Medical School, Senftenberg
Health by digitization and networked IT using distributed embedded systems
Michael Hübner, Brandenburg University of Technology Cottbus-Senftenberg
Age-Related Cell Alterations
Cell-based Immuno-Assays in In-Vitro-Diagnostics – from Tuberculosis to Covid-19
Werner Dammermann, Brandenburg Medical School, Brandenburg an der Havel
Molecular Mechanisms of cardiovascular Diseases
Stefanie Oess, Brandenburg Medical School, Brandenburg an der Havel
Program With Confirmed Speakers: Titles and Speakers are Subject to Change Without Notice